Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.
Aged, 80 and over
Drug Dosage Calculations
Health Knowledge, Attitudes, Practice
Patient Education as Topic
Practice Patterns, Physicians'
Proportional Hazards Models
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info
Showing items related by title, author, creator, and subject.
Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure. Thomas, Kevin L; Piccini, Jonathan P; Liang, Li; Fonarow, Gregg C; Yancy, Clyde W; Peterson, Eric D; Hernandez, Adrian F; ... (8 authors) (J Am Heart Assoc, 2013-09-26)BACKGROUND: The intersection of heart failure (HF) and atrial fibrillation (AF) is common, but the burden of AF among black patients with HF is poorly characterized. We sought to determine the prevalence of AF, characteristics, ...
Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry. Fosbol, Emil L; Holmes, DaJuanicia N; Piccini, Jonathan P; Thomas, Laine; Reiffel, James A; Mills, Roger M; Kowey, Peter; ... (11 authors) (J Am Heart Assoc, 2013-07-18)BACKGROUND: The prevalence of atrial fibrillation (AF) continues to increase; however, there are limited data describing the division of care among practitioners in the community and whether care differs depending on provider ...
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. Gibson, C Michael; Pinto, Duane S; Chi, Gerald; Arbetter, Douglas; Yee, Megan; Mehran, Roxana; Bode, Christoph; ... (19 authors) (Circulation, 2017-01-24)BACKGROUND: Patients with atrial fibrillation who undergo intracoronary stenting traditionally are treated with a vitamin K antagonist (VKA) plus dual antiplatelet therapy (DAPT), yet this treatment leads to high risks of ...